TCI Wealth Advisors, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,251
-5.4%
350.0%0.00%
Q4 2022$1,322
-33.9%
350.0%0.00%
Q3 2022$2,000
+100.0%
350.0%0.00%
Q2 2022$1,0000.0%350.0%0.00%
Q1 2022$1,0000.0%350.0%0.00%
Q4 2021$1,000
-83.3%
35
-79.9%
0.00%
-100.0%
Q3 2021$6,0000.0%174
+20.8%
0.00%0.0%
Q2 2021$6,000
+200.0%
144
+311.4%
0.00%0.0%
Q1 2021$2,0000.0%350.0%0.00%0.0%
Q4 2020$2,0000.0%350.0%0.00%0.0%
Q3 2020$2,0000.0%350.0%0.00%0.0%
Q2 2020$2,000
-33.3%
35
-34.0%
0.00%0.0%
Q1 2020$3,0000.0%530.0%0.00%0.0%
Q4 2019$3,000
-25.0%
53
-11.7%
0.00%
-50.0%
Q3 2019$4,0000.0%60
-9.1%
0.00%0.0%
Q2 2019$4,000
-20.0%
660.0%0.00%0.0%
Q1 2019$5,000
+25.0%
660.0%0.00%0.0%
Q4 2018$4,0000.0%66
-12.0%
0.00%0.0%
Q3 2018$4,0000.0%75
-19.4%
0.00%0.0%
Q2 2018$4,000
+33.3%
93
+40.9%
0.00%
+100.0%
Q1 2018$3,0000.0%660.0%0.00%0.0%
Q4 2017$3,0000.0%660.0%0.00%0.0%
Q3 2017$3,0000.0%660.0%0.00%
-50.0%
Q2 2017$3,0000.0%660.0%0.00%0.0%
Q1 2017$3,0000.0%66
+24.5%
0.00%0.0%
Q4 2016$3,000
-50.0%
53
-67.7%
0.00%
-33.3%
Q3 2016$6,000
+500.0%
164
+368.6%
0.00%
+200.0%
Q2 2016$1,0000.0%350.0%0.00%0.0%
Q1 2016$1,000
-50.0%
350.0%0.00%0.0%
Q4 2015$2,000350.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders